Cargando…
New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
BACKGROUND: Targeted PCR-based genetic testing for BRCA1 and BRCA2 can be performed at a lower cost than full gene testing; however, it may overlook mutations responsible for familial breast and/or ovarian cancers. In the present study, we report the utility of next generation sequencing (NGS) to id...
Autores principales: | Kluska, Anna, Balabas, Aneta, Paziewska, Agnieszka, Kulecka, Maria, Nowakowska, Dorota, Mikula, Michal, Ostrowski, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429836/ https://www.ncbi.nlm.nih.gov/pubmed/25948282 http://dx.doi.org/10.1186/s12920-015-0092-2 |
Ejemplares similares
-
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
por: Kluska, Anna, et al.
Publicado: (2017) -
Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer
por: Niwinska, Anna, et al.
Publicado: (2020) -
Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases
por: Brozek, Izabela, et al.
Publicado: (2012) -
Signatures of circulating microRNA in four sarcoma subtypes
por: Kosela-Paterczyk, Hanna, et al.
Publicado: (2020) -
Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases
por: Ostrowski, Jerzy, et al.
Publicado: (2019)